![DSpace logo](/jspui/image/logo.gif)
Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13517
Title: | Promising novel therapeutic targets for kidney disease: Emphasis on kidney-specific proteins |
Authors: | Gaikwad, Anil Bhanudas |
Keywords: | Pharmacy Novel therapeutic targets Existing therapies Acute Kidney Injury (AKI) Chronic kidney diseases (CKD) Intermedin |
Issue Date: | Feb-2023 |
Publisher: | Elsevier |
Abstract: | Kidney diseases can be defined as abnormalities in the kidney structure, and loss of kidney function, which can progress to kidney failure and uremic death [1]. The pathogenesis of kidney diseases can arise from environmental and genetic factors. Epidemiological studies suggest that more than 850 million individuals have kidney disease worldwide, predicting that, by 2040, such disease will become the fifth leading cause of death [2]. Kidney diseases can be broadly classified into acute kidney disease (AKD) and chronic kidney disease (CKD) [3]. AKD, such as acute kidney injury (AKI), is a condition indicated by an abrupt onset of kidney malfunction [4]. Clinically, AKI is defined by an increase in serum creatinine levels and a reduction in urinary output [5]. By contrast, CKD is characterized by changes in kidney structure and function lasting for more than 3 months (e.g., by a decreased glomerular filtration rate (<60 ml/min/1.73 m2), elevated levels of blood urea nitrogen (BUN), uric acid, creatinine, alongside abnormal urinary albumin excretion) |
URI: | https://www.sciencedirect.com/science/article/pii/S1359644622004597 http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13517 |
Appears in Collections: | Department of Pharmacy |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.